Inogen (INGN) EPS (Weighted Average and Diluted) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.49% |
| Dec 31, 2025 | -3.26% |
| Sep 30, 2025 | -20.11% |
| Jun 30, 2025 | -26.58% |
| Mar 31, 2025 | -28.99% |
| Dec 31, 2024 | -46.87% |
| Sep 30, 2024 | -22.92% |
| Jun 30, 2024 | -20.43% |
| Mar 31, 2024 | -35.59% |
| Dec 31, 2023 | -35.64% |
| Sep 30, 2023 | -36.27% |
| Jun 30, 2023 | -21.49% |
| Mar 31, 2023 | -30.83% |
| Dec 31, 2022 | -141.81% |
| Sep 30, 2022 | -26.76% |
| Jun 30, 2022 | -19.08% |
| Mar 31, 2022 | -33.85% |
| Dec 31, 2021 | -43.29% |
| Sep 30, 2021 | 16.22% |
| Jun 30, 2021 | -9.38% |
| Mar 31, 2021 | -17.61% |
| Dec 31, 2020 | -26.27% |
| Sep 30, 2020 | -21.20% |
| Jun 30, 2020 | -6.73% |
| Mar 31, 2020 | -23.52% |
| Dec 31, 2019 | -23.36% |
| Sep 30, 2019 | 23.03% |
| Jun 30, 2019 | 32.55% |
| Mar 31, 2019 | 91.86% |
| Dec 31, 2018 | -11.05% |
| Sep 30, 2018 | 16.94% |
| Jun 30, 2018 | -0.60% |
| Mar 31, 2018 | 16.34% |